We found no differences between males and females in
age at baseline visit,
ethnicity/race,
FXTAS stage, or
CGG repeat length.
@tbl-biomarker-list lists the `r outcomes_name`s and their ordinal levels
and reports percentages of clinically elevated levels at baseline visit,
stratified by sex.
We found significant sex differences in
percentages of clinically elevated (non-reference)
`r outcomes_name` levels
at baseline visit for `r report_sex_differences(biomarkers_table)`.
